In 1954 we (Price and Kneeland) described a mucoid form of Micrococcus pyogenes var. aureus (Staphylococcus aureus) which showed capsular swelling with homologous immune serum. This mucoid variant, designated RL-mucoid, was derived from the parent RL strain after passage through embryonated eggs with influenza virus. Attempts to reproduce this variation by passing RL through embryonated eggs on subsequent occasions were unsuccessful. The original RLmucoid variant, however, could be maintained indefinitely on subculture, provided that an occasional egg passage was performed if the strain appeared to be losing its mucoid character.
METHODS AMD MATERIALS
The techniques employed in culturing the organisms, demonstrating capsular swelling, producing antiserum, and performing the coagulase tests were described in our previous publication. Alpha toxin was demonstrated by the method of Elek and Levy (1950) . Adsorption of antibody from serum was done by the method of Cowan (1939) .
The sources of the 39 additional strains of staphylococci studied were as follows: From The amount of capsular substance produced varies from strain to strain, being much greater in mucoid strains, but is antigenically similar in all strains studied. It does not appear to be quantitatively related to virulence.
Several strains, all isolated from nonpathological sources, which did not produce alpha toxin, and were mannitol-and coagulase-negative, did not give rise to capsular substanc.
